Login / Signup

Psychotropic Drugs Reemerging as Headache Medicines.

Emmanuelle Andree Danielle Schindler
Published in: CNS drugs (2024)
Scientific and public attention on the therapeutic effects of psychedelics and other psychoactive compounds in headache disorders has recently grown. The use and reported therapeutic effects of such treatments have long been reported, though formal clinical trials are only recently taking place. When considering how these substances might be further studied and eventually applied, it is important to consider the specific headache disorder, the particular drug, and the mode of use. No singular protocol will be applicable across all headache disorders and drugs. In this leading article, the nuance required to consider the value of classic psychedelics, ketamine, and cannabinoids as headache medicines is presented.
Keyphrases
  • clinical trial
  • healthcare
  • randomized controlled trial
  • emergency department
  • pain management
  • drug induced
  • chronic pain
  • open label
  • study protocol